CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,796,000 | -8.1% | 4,030,000 | +39.0% | 0.34% | +1.8% |
| Q2 2022 | $5,220,000 | +71.1% | 2,900,000 | +92.1% | 0.33% | +149.2% |
| Q1 2022 | $3,050,000 | +11.4% | 1,510,000 | +49.5% | 0.13% | +40.4% |
| Q4 2021 | $2,738,000 | -68.5% | 1,010,000 | +381.6% | 0.09% | -80.0% |
| Q2 2014 | $8,685,000 | -67.8% | 209,735 | -46.2% | 0.47% | -69.6% |
| Q1 2014 | $26,997,000 | +12.3% | 389,735 | -2.3% | 1.54% | +9.6% |
| Q4 2013 | $24,038,000 | +14.6% | 398,835 | +15.6% | 1.41% | -1.3% |
| Q3 2013 | $20,974,000 | -49.3% | 344,960 | -44.2% | 1.43% | -48.7% |
| Q2 2013 | $41,372,000 | – | 617,678 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |